BIONIK LABORATORIES CORP.: 10-Q filed 2012-08-07

Name: BIONIK LABORATORIES CORP.: 10-Q filed 2012-08-07
Creator: BIONIK LABORATORIES CORP.

What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2012-08-07 (fiscal FY 2012): 12 published measures, 26 facts as tagged in accession 0001471242-12-001044.

This filing

Form: 10-Q (quarterly report)
Filed: 2012-08-07
Fiscal period: fiscal FY 2012
Accession: 0001471242-12-001044 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-06-30	14,427	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2012-06-30	6,515	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-06-30	7,912	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	3,711	USD	91
2012-01-01 to 2012-06-30	1,789	USD	182
2010-01-08 to 2012-06-30	-10,738	USD	905
2011-01-01 to 2011-06-30	-1,200	USD	181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	4,000	USD	91
2012-01-01 to 2012-06-30	5,500	USD	182
2010-01-08 to 2012-06-30	19,204	USD	905
2011-01-01 to 2011-06-30	2,000	USD	181

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	4,988,500	shares	91
2012-01-01 to 2012-06-30	4,988,500	shares	182
2011-04-01 to 2011-06-30	4,900,000	shares	91
2011-01-01 to 2011-06-30	4,900,000	shares	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-06-30	14,427	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	-90	USD	91
2012-01-01 to 2012-06-30	-183	USD	182
2010-01-08 to 2012-06-30	-365	USD	905

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-06-30	6,515	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-06-30	13,661	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-06-30	515	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-04-01 to 2012-06-30	199	USD	91
2012-01-01 to 2012-06-30	3,528	USD	182
2010-01-08 to 2012-06-30	29,277	USD	905
2011-01-01 to 2011-06-30	3,200	USD	181

Inspect the source

Entity: BIONIK LABORATORIES CORP. / CIK 0001508381
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))